NKGN
NKGen Biotech Inc. Common Stock
Save
41.07M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses.
Similar securities
Based on sector and market capitalization
Report issue